DE602005012097D1 - Adjuvante zusammensetzung und anwendungsverfahren dafür - Google Patents
Adjuvante zusammensetzung und anwendungsverfahren dafürInfo
- Publication number
- DE602005012097D1 DE602005012097D1 DE602005012097T DE602005012097T DE602005012097D1 DE 602005012097 D1 DE602005012097 D1 DE 602005012097D1 DE 602005012097 T DE602005012097 T DE 602005012097T DE 602005012097 T DE602005012097 T DE 602005012097T DE 602005012097 D1 DE602005012097 D1 DE 602005012097D1
- Authority
- DE
- Germany
- Prior art keywords
- adjuvant composition
- vaccine
- application therefor
- gammadeltat
- directed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002671 adjuvant Substances 0.000 title 1
- 239000012190 activator Substances 0.000 abstract 2
- 210000004698 lymphocyte Anatomy 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 239000012646 vaccine adjuvant Substances 0.000 abstract 2
- 229940124931 vaccine adjuvant Drugs 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56495904P | 2004-04-26 | 2004-04-26 | |
US62906904P | 2004-11-18 | 2004-11-18 | |
PCT/IB2005/001485 WO2005102385A1 (en) | 2004-04-26 | 2005-04-25 | Adjuvant composition and methods for its use |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005012097D1 true DE602005012097D1 (de) | 2009-02-12 |
Family
ID=34969994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005012097T Active DE602005012097D1 (de) | 2004-04-26 | 2005-04-25 | Adjuvante zusammensetzung und anwendungsverfahren dafür |
Country Status (8)
Country | Link |
---|---|
US (1) | US20070218086A1 (de) |
EP (1) | EP1761278B1 (de) |
JP (1) | JP2007534743A (de) |
AT (1) | ATE419008T1 (de) |
AU (1) | AU2005235271A1 (de) |
CA (1) | CA2564562A1 (de) |
DE (1) | DE602005012097D1 (de) |
WO (1) | WO2005102385A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0212666D0 (en) * | 2002-05-31 | 2002-07-10 | Secr Defence | Immunogenic sequences |
US20070134273A1 (en) * | 2004-02-10 | 2007-06-14 | Francois Romagne | Composition and method for the treatment of carcinoma |
WO2006067635A2 (en) * | 2004-12-20 | 2006-06-29 | Innate Pharma S.A. | USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT |
CN101146575A (zh) * | 2005-03-22 | 2008-03-19 | 依奈特制药公司 | 新类型的γδT细胞活化剂及其应用 |
WO2007028985A2 (en) * | 2005-09-07 | 2007-03-15 | The Secretary Of State For Defence | Adjuvanted vaccine |
ITMI20060366A1 (it) * | 2006-03-01 | 2007-09-02 | C4T S C A R L | Composti organo tiopirosfosfati metodo per prepararli e composizioni che li contengono |
EP1878440A1 (de) * | 2006-07-13 | 2008-01-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Verfahren und zusammensetzungen zur erhöhung der effizienz von therapeutischen antikörpern mit gamma delta zellaktivatoren |
GB2453475B (en) * | 2006-07-25 | 2011-01-19 | Secr Defence | Live vaccine strain |
EP2123285A1 (de) * | 2008-05-21 | 2009-11-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Nucleosid-Phosphorantigene zur Verwendung in der VGAMMA9VDELTA2-T-Zellen-vermittelten Therapie |
WO2010029062A1 (en) | 2008-09-10 | 2010-03-18 | Innate Pharma | Novel polymorphic form of chdmapp, method of preparation thereof, and pharmaceutical composition comprising same |
ES2564183T3 (es) * | 2008-09-29 | 2016-03-18 | Cadila Pharmaceuticals Ltd. | Adyuvantes de vacuna |
GB0901411D0 (en) * | 2009-01-29 | 2009-03-11 | Secr Defence | Treatment |
AU2014233424B2 (en) * | 2013-03-15 | 2017-03-16 | The Trustees Of The University Of Pennsylvania | Vaccines with biomolecular adjuvants |
KR102451441B1 (ko) * | 2020-06-25 | 2022-10-12 | 대한민국 | 신규 면역증강제 및 이를 포함하는 백신 조성물 |
CN115916255A (zh) * | 2020-06-26 | 2023-04-04 | 大韩民国(动植物检疫局) | 新型免疫刺激剂和包含其的疫苗组合物 |
AU2022302784A1 (en) * | 2021-06-28 | 2023-12-21 | Byondis B.V. | Conjugates comprising phosphoantigens and their use in therapy |
GB202114311D0 (en) * | 2021-10-06 | 2021-11-17 | Molecular Attraction Ab | New compositions |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8913737D0 (en) | 1989-06-15 | 1989-08-02 | Univ Birmingham | A novel anti-allergy treatment |
US5639653A (en) | 1993-07-19 | 1997-06-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva Universtiy | Method for proliferating Vγ2Vδ2 T cells |
US5688506A (en) | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
WO1998050567A1 (en) | 1997-05-02 | 1998-11-12 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the prostate |
BE1011282A3 (fr) * | 1997-07-14 | 1999-07-06 | Solvay | Composition a base de polyethylene et procede de fabrication d'objets faconnes a partir de la composition. |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
FR2782722B1 (fr) * | 1998-09-01 | 2001-01-12 | Inst Nat Sante Rech Med | Nouveaux composes phosphoepoxydes, procede de fabrication et applications |
FR2782721B1 (fr) | 1998-09-01 | 2000-11-03 | Inst Nat Sante Rech Med | Nouveaux composes phosphohalohydrines, procede de fabrication et applications |
DE50212935D1 (de) | 2001-07-20 | 2008-12-04 | Bioagency Ag | Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen |
JP2005500336A (ja) | 2001-07-25 | 2005-01-06 | ニューヨーク・ユニバーシティ | 感染および癌に対するワクチンのためのアジュバントとしてのグリコシルセラミドの使用 |
WO2003038072A1 (en) * | 2001-10-31 | 2003-05-08 | Universite Libre De Bruxelles | Generation and use of new types of dendritic cells |
FR2833266B1 (fr) * | 2001-12-11 | 2004-10-22 | Mayoly Spindler Lab | Nouveaux derives phosphonates, leur procede de preparation, leur utilisation comme modulateurs de l'activite des lymphocytes tgamma9 delta2 |
EP1426052B1 (de) | 2002-12-02 | 2009-09-02 | Innate Pharma | Interleukin-2 und Gamma Delta T Zellaktivator enthaltende Zusammensetzungen und deren Verwendungen |
US20070025960A1 (en) * | 2003-05-16 | 2007-02-01 | University Of Maryland Biotechnology Institute | Bisphosphonates for prophylaxis and therapy against bioterrorism agents |
CA2547008A1 (en) | 2003-12-02 | 2005-06-16 | Innate Pharma | New class of gamma delta t cells activators and use thereof |
-
2005
- 2005-04-25 AU AU2005235271A patent/AU2005235271A1/en not_active Abandoned
- 2005-04-25 EP EP05747242A patent/EP1761278B1/de not_active Not-in-force
- 2005-04-25 JP JP2007510157A patent/JP2007534743A/ja not_active Withdrawn
- 2005-04-25 DE DE602005012097T patent/DE602005012097D1/de active Active
- 2005-04-25 US US11/587,476 patent/US20070218086A1/en not_active Abandoned
- 2005-04-25 CA CA002564562A patent/CA2564562A1/en not_active Abandoned
- 2005-04-25 WO PCT/IB2005/001485 patent/WO2005102385A1/en active Application Filing
- 2005-04-25 AT AT05747242T patent/ATE419008T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE419008T1 (de) | 2009-01-15 |
EP1761278A1 (de) | 2007-03-14 |
AU2005235271A1 (en) | 2005-11-03 |
US20070218086A1 (en) | 2007-09-20 |
EP1761278B1 (de) | 2008-12-31 |
CA2564562A1 (en) | 2005-11-03 |
JP2007534743A (ja) | 2007-11-29 |
WO2005102385A1 (en) | 2005-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005012097D1 (de) | Adjuvante zusammensetzung und anwendungsverfahren dafür | |
EA200700702A1 (ru) | Аналоги локсапина и способы их применения | |
EA200800812A1 (ru) | Композиции антитела против cd3 | |
IL244803B (en) | Human anti-beta antibodies and their use | |
NO20083895L (no) | Anti-IGF-1R human monoklonalantibody formulering | |
ATE426412T1 (de) | Adjuvante influenza-vakzine | |
EA200801427A1 (ru) | Молекулы антитела со специфической активностью в отношении интерлейкина-6 (ил-6) человека | |
BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
EA201400933A1 (ru) | Агенты, связывающие склеростин | |
IS7133A (is) | Afleiða beta-amyloid - T-frumu-mótefnavísisbóluefni | |
AR057253A1 (es) | Anticuerpos anti-ox40l y metodos que los utilizan | |
DE602004028468D1 (de) | Haltung von immunantworten gegen mhc-klasse-i-beschränkte epitope, für prophylaktische oder therapeutische zwecke | |
DK1773885T3 (da) | Humaniserede anti-c-met-antagonister | |
NO20074238L (no) | Fiksert dosering av HER-antistoffer | |
AR061246A1 (es) | Anticuerpos anti- dill4 y metodos que los usan | |
DK1668001T3 (da) | Substituerede heteroarylbenzofuransyrer | |
MX2007002787A (es) | Adyuvante de glicosilceramida para antigenos de sacarido. | |
NO20071937L (no) | Fremgangsmater og mellomprodukter for fremstilling av cysteinproteaseinhibitorer | |
EA200701305A1 (ru) | Иммуногенные композиции, содержащие циклические пептиды, полученные из бета-амилоидного пептида | |
WO2006067635A3 (en) | USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT | |
NO20062579L (no) | Preparater som omfatter melittin-avledede peptider og fremgangsmate for styrking av immunresponser mot malantigener | |
AR059851A1 (es) | Anticuerpos de la egfl7 y metodos de uso | |
EA200601743A1 (ru) | Выделенный полипептид реналазы и его применение | |
ATE422367T1 (de) | Zusammensetzungen aus demethylierenden mitteln als verstärker der immuntherapie zur behanldung von chronischen infektionen und neoplastischen erkrankungen und behandlungsverfahren dafür | |
EA201200538A1 (ru) | Арабиногалактан для повышения приобретенного иммунного ответа |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |